No association between schizophrenia and polymorphisms within the genes for debrisoquine 4‐hydroxylase (CYP2D6) and the dopamine transporter (DAT)

Abstract

It has been suggested that the cytochrome P450 mono‐oxygenase, debrisoquine 4‐hydroxylase, is involved in the catabolism and processing of neurotransmitters subsequent to their reuptake into target cells. It is also thought to be related to the dopamine transporter that acts to take released dopamine back up into presynaptic terminals. The present study used the association approach to test the hypothesis that mutations in the genes for debrisoquine 4‐hydroxylase (CYP2D6) and the dopamine transporter (DAT) confer susceptibility to schizophrenia. There were no differences in allele or genotype frequencies between patients and controls in the mutations causing the poor metaboliser phenotype in CYP2D6. In addition there was no association found between schizophrenia and a 48bp repeat within the 3′ untranslated region of DAT.